Although improvements in insulin sensitivity are likely more relevant to clinical populations at an increased susceptibility to metabolic disease(s), even in healthy individuals, insulin sensitivity is an independent predictor of future cardiovascular disease (42, 43). This evidence concerns the gene INS and metabolic disease.